The glucagon-like peptide-1 (GLP-1) drugs poised to conquer obesity

被引：0
|
作者：
Yin, Jun [1 ]
Liu, Yuexing [1 ]
Jia, Weiping [1 ,2 ]
机构：
[1] Department of Endocrinology and Metabolism, Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiaotong University, School of Medicine, Shanghai,200233, China
[2] Institute for Proactive Healthcare, Shanghai Jiao Tong University, Shanghai,200030, China
来源：
Chinese Science Bulletin | 2024年 / 69卷 / 35期
关键词：
D O I：
10.1360/TB-2024-0417
中图分类号：
学科分类号：
摘要：
43
引用
收藏
页码：5094 / 5099
相关论文
共 50 条
  • [41] CLONING AND FUNCTIONAL EXPRESSION OF THE HUMAN GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR
    DILLON, JS
    TANIZAWA, Y
    WHEELER, MB
    LENG, XH
    LIGON, BB
    RABIN, DU
    YOOWARREN, H
    PERMUTT, MA
    BOYD, AE
    ENDOCRINOLOGY, 1993, 133 (04) : 1907 - 1910
  • [42] Comparison of efficacy of weekly glucagon-like peptide-1 (GLP-1) analogue therapies
    Thant, A. A.
    Atkinson, R.
    Kapoor, A.
    Lowe, G.
    Basu, A.
    Bharaj, H.
    Basu, A.
    Banerjee, M.
    DIABETIC MEDICINE, 2021, 38
  • [43] Glucagon-Like Peptide-1 (GLP-1) in the Integration of Neural and Endocrine Responses to Stress
    Diz-Chaves, Yolanda
    Herrera-Perez, Salvador
    Gonzalez-Matias, Lucas C.
    Lamas, Jose Antonio
    Mallo, Federico
    NUTRIENTS, 2020, 12 (11) : 1 - 32
  • [44] Can glucagon-like peptide-1 (GLP-1) analogues make neuroprotection a reality?
    Basalay, Maryna V.
    Davidson, Sean M.
    Yellon, Derek M.
    NEURAL REGENERATION RESEARCH, 2020, 15 (10) : 1852 - 1853
  • [45] Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits-The role of the GLP-1 receptor
    Helmstaedter, Johanna
    Keppeler, Karin
    Kuester, Leonie
    Muenzel, Thomas
    Daiber, Andreas
    Steven, Sebastian
    BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (04) : 659 - 676
  • [46] Addition of a cysteine to glucagon-like peptide-1 (GLP-1) conjugates GLP-1 to albumin in serum and prolongs GLP-1 action in vivo
    Wu, Ye-Lin
    Huang, Jing
    Xu, Jin
    Liu, Jian
    Feng, Zhen
    Wang, Yang
    Lai, Yuping
    Wu, Zi-Rong
    REGULATORY PEPTIDES, 2010, 164 (2-3) : 83 - 89
  • [47] Glucagon-like peptide 1 (GLP-1) and metabolic diseases
    C. M. Rotella
    L. Pala
    E. Mannucci
    Journal of Endocrinological Investigation, 2005, 28 : 746 - 758
  • [48] Glucagon-like peptide 1 (GLP-1) in the treatment of diabetes
    Nauck, MA
    HORMONE AND METABOLIC RESEARCH, 2004, 36 (11-12) : 852 - 858
  • [49] Glucagon-like peptide 1 (GLP-1) in diabetes and aging
    D'Alessio, D
    JOURNAL OF ANTI-AGING MEDICINE, 2000, 3 (03): : 329 - 333
  • [50] Glucagon-like peptide 1(GLP-1) in biology and pathology
    Meier, JJ
    Nauck, MA
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2005, 21 (02) : 91 - 117
12345